Table 1 (abstract A29). See text for description
Characteristic | Proportion or Summary Statistic |
|---|---|
Age (mean (sd)) | 7.0 (4.5) |
Female (%) | 40% |
White Race (%) | 68% |
Black Race (%) | 11% |
Other Race (%) | 22% |
Elapsed Days Since Onset of Symptoms (mean (sd)) | 40 (46) |
Elapsed Days Since Diagnosis (mean (sd)) | 6 (8) |
Physician Global Assessment (mean (sd)) | 5.9 (2.2) |
Parent Global Assessment (mean (sd)) | 5.1 (3.3) |
Number of Active Joints (mean (sd)) | 6.4 (8.0) |
sJIA rash (%) | 85% |
Generalized lymphadenopathy (%) | 25% |
Hepatomegaly (%) | 15% |
Splenomegaly (%) | 15% |
Serositis (%) | 13% |
Morning Stiffness >15 minutes (%) | 37% |
ESR (median (IQR)) | 71 (44-100) |
C-RP (median (IQR)) | 12.3 (6.2-53.3) |
Ferritin (median (IQR)) | 700 (236-1266) |
Hemoglobin (median (IQR)) | 10.1 (9.1-11.1) |
WBC (median (IQR)) | 14.7 (9.8-20.2) |
Platelets (median (IQR)) | 453 (335-564) |
AST (median (IQR)) | 34 (23-46) |
ALT (median (IQR)) | 33 (16-51) |
CHAQ (mean (sd)) | 1.1 (0.9) |
Pain VAS (mean (sd)) | 2.9 (2.7) |